Search

11 results for “Retatrutide”

Retatrutide
Clinical trial data
Metabolic

Retatrutide

LY3437943 · Acylated tri-agonist peptide (GLP-1 / GIP / glucagon receptor)

Half-life~6.0 days
RouteSubQ injection
Sign in for detailsView
Survodutide
Clinical trial data
Metabolic

Survodutide

Half-life~5.5 days
RouteSubQ injection
Sign in for detailsView
Tirzepatide
Approved therapeutic
Metabolic

Tirzepatide

Half-life~5.0 days
RouteSubQ injection
Sign in for detailsView
SS-31 (Elamipretide)
Clinical trial data
Longevity

SS-31 (Elamipretide)

Half-life~4.5 hours
RouteSubQ injection
Sign in for detailsView
Cagrilintide 5mg + Semaglutide 5mg (Blend)
Clinical trial data
BlendsMetabolic

Cagrilintide 5mg + Semaglutide 5mg

Half-life~7 days
RouteSubQ injection
Sign in for detailsView
Semaglutide
Approved therapeutic
Metabolic

Semaglutide

Half-life~7 days
RouteSubQ injection
Sign in for detailsView
Cagrilintide
Clinical trial data
Metabolic

Cagrilintide

Half-life~7 days
RouteSubQ injection
Sign in for detailsView
Adipotide
Preclinical only
Metabolic

Adipotide

Half-life~3 hours
RouteSubQ injection
Sign in for detailsView
Sermorelin Acetate
Approved therapeutic
Growth

Sermorelin Acetate

Half-life~15 minutes
RouteSubQ injection
Sign in for detailsView
Hexarelin
Preclinical only
Growth

Hexarelin

Half-life~1 hours
RouteSubQ injection
Sign in for detailsView
NAD+ (Injectable)
Early human data
LongevityMetabolic

NAD+ (Injectable)

Half-life~45 minutes
RouteSubQ injection
Sign in for detailsView